RealFeedApp Sanofi launches autonomous new protein design
Companies like Sanofi are adopting AI models for de novo protein design, utilizing large datasets to optimize drug development.
- Field
- genetics and genomes
- What they did
- Researchers described how artificial intelligences use large amounts of data to design new proteins that could accelerate drug development.
- Why it matters
- This will help companies reduce time and costs, as the current process of testing promising candidates in early stages often leads to their failure.
#protein design#ai#sanofi#drug development#de novo
